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Edited by Sandro SonninoAbstract EF-hand proteins are known to translocate to mem-
branes, suggesting that they are involved in signaling events
located in the cell membrane. Many proteins involved in
signaling events associate cholesterol rich membrane domains,
so called lipid rafts, which serve as platforms for controlled
protein–protein interaction. Here, we demonstrate that the
myeloid expressed EF-hand proteins can be distinguished into
three classes with respect to their membrane association.
Grancalcin, a myeloid expressed penta EF-hand protein, is
constitutively located in lipid rafts. S100A9 (MRP14) and
S100A8 (MRP8) are translocated into detergent resistant lipid
structures only after calcium activation of the neutrophils.
However, the S100A9/A8 membrane association is cholesterol
and sphingolipid independent. On the other hand, the association
of S100A12 (EN-RAGE) and S100A6 (calcyclin) with mem-
branes is detergent sensitive. These diverse aﬃnities to lipid
structures of the myeloid expressed EF-hand proteins most likely
reﬂect their diﬀerent functions in neutrophils.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The calcium binding EF-hand domain is a common motif
characterizing a large family of proteins speciﬁcally expressed
in various cell types. Due to their calcium binding properties,
they are thought to play a pivotal role in a variety of signaling
pathways [1]. Furthermore, they are known for their ability to
translocate to membranes in a calcium-dependent manner [2].
Selective recruitment of proteins from the cytoplasm to the
membrane can regulate signaling events, such as those down-
stream of growth factor addition, ion channel activation, or
changes in cell adhesion. Lipid–lipid interactions can organize
membranes into detergent-resistant domains, so called lipid
rafts. These domains have been proposed as platforms for the
controlled interaction of substrates and signaling enzymes.
Many signaling proteins are known to be organized in lipid
rafts, including heterotrimeric G proteins and members of the
Src family of protein tyrosine kinases, which are dually acyl-
ated [3].
In myeloid cells changes in [Ca2þ]i have been associated with
multiple functions, including activation of cellular kinases and* Corresponding author. Fax: +49-251-835-6549.
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regulation of cytoskeletal binding proteins, transcriptional
control, and modulation of surface receptors. The S100 pro-
teins S100A9 (MRP14), and S100A8 (MRP8), S100A12,
S100A6 (calcyclin) and the penta EF-hand protein grancalcin,
all members of the calcium binding EF-hand protein family,
are expressed in a myeloid speciﬁc manner. They are translo-
cated in a calcium-dependent manner to the cell membrane [4–
7], although the sequences of these proteins do neither encode
a signal peptide nor any other sequence known to mediate
membrane association. Nevertheless, the calcium-dependent
membrane association suggests that they may be involved in
the calcium-dependent signaling processes. However, nothing
is known about their localization in lipid rafts.
Here, we report that the EF-hand proteins show a diverse
and protein-speciﬁc pattern of membrane and lipid raft asso-
ciation, which most likely reﬂects a functional diversity of
these proteins in granulocytes.2. Materials and methods
2.1. Chemicals and antibodies
Preparation of anti-human S100A9, S100A8 and S100A12 anti-
bodies was described earlier [8,9]. Anti-human S100A6 antibody was
generously provided by C.W. Heizmann, Z€urich. Human grancalcin
was recombinantly expressed as his-tagged protein in Escherichia coli
using pQE-32 (Qiagen, D€usseldorf, Germany) as expression vector.
His-tagged grancalcin was puriﬁed by Ni–NTA aﬃnity column fol-
lowing the manufacturer’s instructions (Qiagen, D€usseldorf). Puriﬁed
his-tagged grancalcin was used to immunize rabbits and IgG speciﬁc
antibodies were ﬁnally isolated by protein G Sepharose aﬃnity puri-
ﬁcation of rabbit serum. The ﬂotillin-1 antibody was purchased from
BD Biosciences Pharmingen (USA).
All stimulating agents were purchased from Sigma (St. Louis, USA).
2.2. Preparation of granulocytes
Granulocytes were isolated from human buﬀy coats as described
elsewhere [10]. Brieﬂy, the whole blood sample was diluted with
complete spinner medium and overlaid on Biocoll (1.077 mg/ml). After
centrifugation, the erythrocytes in the cell pellet were lysed in ice cold
water and the remaining granulocytes were washed in phosphate
buﬀered saline. Finally, the granulocytes were incubated in Hanks’
buﬀers saline (HBSS). Where indicated cells were treated for 10 min at
37 C with 5 lM nocodazole (NOCOD), 10 lM cytochalasin D
(CytD), 50 lM phospholipase A2 inhibitor AACOCF3 (PLA2I) or 1
lM PMA either in the presence of 5 lM A23187 or 2 mM EDTA.
Methyl-b-cyclodextrin (MCD): cells were pre-treated for 30 min at 37
C with 10 lM MCD to deplete cholesterol. After stimulation, cells
were collected by centrifugation and resuspended in 2-(N-morpho-
lino)ethanesulfate buﬀer (25 mM MES, pH 6.5; 150 mM NaCl; pro-
tease inhibitors) with 1% Triton X-100.blished by Elsevier B.V. All rights reserved.
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Granulocytes were incubated in MES-buﬀer (25 mM MES, pH 6.5;
150 mM NaCl; protease inhibitors) containing 1% Triton X-100 at 4
C for 20 min and then homogenized using a loose-ﬁtting Dounce
homogenizer (10 strokes). The homogenates (corresponding to 3 107
cells) were then adjusted to 40% sucrose by the addition of an equal
volume of 80% sucrose solution prepared in the above buﬀer, but
lacking Triton X-100, placed in the bottom of ultracentrifuge tubes,
and then overlaid with a discontinuous sucrose gradient of 4 ml 30%
(w/v) sucrose and 4 ml 5% (w/v) sucrose, both prepared in MES buﬀer
lacking Triton X-100. The samples were centrifuged at 35 000 rpm
(200 000· g) in an SW41 rotor (Beckman Instruments) for 16–20 h,
fractionated into 1 ml fractions sequentially from the top of the gra-
dient, and concentrated by precipitation with trichloroacetic acid.
The pellets were dissolved in denaturing L€ammeli loading buﬀer.
Equal quantities of each fraction were loaded onto an SDS–PAGE.
Western blots were performed according to standard procedures and
developed using the ECL PlusTM Western Blotting Detection Reagents
from Amersham Biosciences.
2.4. EGFP-fusion protein expression
Grancalcin and S100A9 were cloned into pEGFP-C1, a vector that
allows the eukaryotic expression of ﬂuorescent GFP-fusion proteins
(BD Bioscience Clontech, USA). The EGFP-hgrancalcin and EGFP-
hS100A9 constructs were transfected into HEK293 cells via electro-
poration. Expression of fusion proteins was veriﬁed by Western blot
analysis (data not shown).3. Results
First, we investigated the association of the penta EF-hand
protein grancalcin with detergent resistant lipid structures.Fig. 1. Granulocytes were incubated with A23187 or with EDTA in
HBSS; MCD: cells were pre-incubated with MCD for 30 min at 37 C.
Subsequently, the cells were lysed with 1% Triton X-100, fractionated
(1–10; p, pellet) via a sucrose gradient and analyzed by Western
blotting using the anti-human grancalcin antibody as probe. The
presence of ﬂotillin-1 as a lipid raft marker protein is shown below.Lipid rafts containing fractions were identiﬁed by the presence
of ﬂotillin-1, a marker protein for granulocytic lipid rafts. We
observed that grancalcin is localized in lipid rafts independent
of calcium (Fig. 1). Grancalcin is also detected in the pellet of
the sucrose gradient conﬁrming its association with cytoskel-
etal proteins [11]. Furthermore, fractionating the lipid rafts
containing fractions a second time via a discontinuous sucrose
gradient grancalcin is still present in the low density, choles-
terol rich fractions as ﬂotillin-1 (Fig. 2), suggesting that
grancalcin can be considered as integral part of granulocytic
lipid rafts. This ﬁnding was conﬁrmed by the addition of
MCD, a cholesterol and sphingolipid-depleting agent [12] that
is commonly used to disrupt lipid rafts. Pre-treating the
granulocytes with MCD grancalcin disappeared from the lipid
raft fractions, indicating that this protein is indeed located in
granulocytic lipid rafts (Fig. 1). To further conﬁrm the sub-
cellular localization of grancalcin, HEK293 cells were trans-
fected with an EGFP-grancalcin encoding vector. The
grancalcin fusion protein is localized around or in the nucleus.
Additionally, ﬂuorescent spots, which may represent fusionFig. 2. The lipid raft containing detergent resistant membrane (DRM)
fractions derived from A23187 treated and EDTA treated granulocytes
were subjected to a second sucrose gradient and subsequently analyzed
by Western blotting for the presence of grancalcin, S100A9 and ﬂo-
tillin-1. Whereas both grancalcin and ﬂotillin-1 remain in the lipid raft
fractions, S100A9 is no longer associated with detergent resistant lipid
structures.
Fig. 3. HEK293 cells were transiently transfected with pEGFP-hgrancalcin (grancalcin) and pEGFP-hS100A9 (S100A9). The expression of the fusion
proteins was conﬁrmed by Western blotting (data not shown). The S100A9 fusion protein is distributed over the whole cell body, whereas the EGFP-
grancalcin protein is located around the cell nucleus. The ﬂuorescent spots visible at the EGFP-hgrancalcin transfected cells may represent EGFP-
hgrancalcin protein in lipid rafts.
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body. The EGFP-S100A9 fusion protein, however, seems to be
distributed over the whole cell body (Fig. 3).
In contrast to grancalcin, the membrane association of
S100A6 (calcyclin) and S100A12 is apparently detergent sen-
sitive. Both proteins are exclusively present in the high density
fractions, which contain the cytosolic and detergent soluble
proteins independent of calcium. They are also not found in
the pellet, indicating that they do not interact with cytoskeletal
proteins in the presence of Triton X-100 (Fig. 4).
S100A9 and S100A8 are found in lipid structures during
phagocyte activation. In resident cells both S100A9 (Fig. 5)
and S100A8 (data not shown) were found in the cytoskeletal
pellet as well in the high density fractions after treatment with
Triton X-100, but not in the low density, lipid rich fractions.
Only after an A23187 induced increase of [Ca2þ]i both proteins
were detected in the low density, lipid containing fractions
(Fig. 5). However, they do not exclusively associate with typ-
ical lipid rafts, since both proteins are also present in low
density fractions other than the ﬂotillin-1 containing lipid raft
fractions. To investigate whether actin or tubulin ﬁlaments are
involved in this translocation, the cells were incubated with
cytochalasin or NOCOD as indicated. NOCOD inhibits the
calcium-dependent redistribution of S100A9/A8, whereas cy-
tochalasin does not. The complex of S100A9/A8 binds ara-
chidonic acid in a calcium-dependent manner [13]. To
investigate the possibility whether membrane association could
be mediated by arachidonic acid during phagocyte activation,
we inhibited the phospholipase A2-dependent release of ara-
chidonic acid from cellular lipids by AACOCF3. However,treatment of the granulocytes with the phospholipase A2 in-
hibitor does not prevent the calcium-dependent shift of
S100A8/A9 into lipid rich fractions (Fig. 5). Next, the ﬂotillin
containing fractions were isolated and a second sucrose frac-
tionation of this lipid raft containing fractions was performed.
Now the S100A9 and S100A8 were detected in the high sucrose
fractions, suggesting that the association with the lipid struc-
tures is quite loose (Fig. 2). Interestingly, upon treatment with
MCD, S100A9/A8 does not shift into other fractions, indi-
cating that their calcium induced membrane association is not
cholesterol and sphingolipid-dependent (Fig. 5).4. Discussion
According to our experiments, the EF-hand proteins can be
classiﬁed into three classes: ﬁrst, proteins that clearly integrate
into lipid rafts as grancalcin. Secondly, those that are not as-
sociated with lipid rafts and whose interaction with membra-
neous and cytoskeletal structures is detergent sensitive.
S100A12 and S100A6 proteins belong to this class of EF-hand
proteins. Thirdly, proteins whose interaction with membranes
is detergent resistant, but not restricted to lipid rafts. They
only associate under cell-activating conditions. S100A9 and A8
are examples for this class of EF-hand proteins.
Grancalcin has been reported to bind to the actin bundling
protein L-plastin. Here, we additionally demonstrate that this
protein is constitutively present in neutrophilic lipid rafts.
Following activation of phagocytes with inﬂammatory stimuli
such as formyl-methionine–leucine–phenylalanine or immune
Fig. 5. Western blot of the sucrose gradient fractions (1–10; p, pellet)
probed with anti-human S100A9. Before lysing cells with Triton X-
100, granulocytes were treated with nocodazole (NOCOD), cytocha-
lasin D (CytD), phospholipase A2 inhibitor AACOCF3 (PLA2I), and
PMA (PMA) either in the presence of A23187 or in the presence of
EDTA as described in Section 2. MCD: cells were pre-treated with
MCD to deplete cholesterol. Probing the Western blot with the anti-
human S100A8 antibody revealed a pattern identical to that of S100A9
(data not shown).
Fig. 4. Western blot of the sucrose gradient fractions probed with anti-
human S100A12 and anti-human S100A6 (calcyclin), respectively, in-
dicating that both proteins are localized in the high density fractions
after Triton X-100 treatment. Cells were incubated either with A23187
or with EDTA, respectively.
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ylated at Ser5, and this in turn leads to integrin activation and
subsequent increased adhesion [11]. It is known that these
processes are mediated by proteins organized in lipid rafts.
Grancalcin is able to interact with L-plastin. Cell stimulation
leads to a cytoplasmic Ca2þ rise with two consequences for L-
plastin: (1) its actin-bundling activity is inhibited, at least in in
vitro experiments [11]; and (2) the L-plastin–grancalcin com-
plex dissociates. Grancalcin might thus regulate adherence and
migration of neutrophils through interaction with L-plastin
[11]. The localization of grancalcin in lipid rafts grancalcin is in
accordance with these ﬁndings.
Furthermore, granulocytes are devoid of the typical marker
protein for lipid rafts, namely caveolin [14]. Thus, we propose
to use grancalcin like ﬂotillin as a novel marker protein for
granulocytic lipid rafts.
S100A12 and S100A6 do not ﬁrmly associate with lipid
structures, since after treatment of the cells with the detergent
Triton X-100 both proteins are exclusively found in the high
density fractions containing the cytosolic and detergent soluble
proteins. However, it has been shown that both translocate to
the membrane upon stimulation [4,7]. Thus, their association is
either loose or mediated by detergent sensitive protein–protein
contacts. Moreover, in contrast to the other EF-hand proteins
both proteins could not be detected in the cytoskeletal fraction
after treatment with the detergent. S100A12 (EN-RAGE) has
been reported to present an inﬂammatory marker protein [8].However, the molecular mechanism by which this protein is
secreted or with which protein it intracellularly interacts is not
understood so far.
S100A6 (calcyclin) is predominantly known to be expressed
in the central nervous system and epithelial cells [15]. Its
presence in neutrophils has been recently documented, but
nothing is known about its speciﬁc role in theses cells [16].
S100A6 translocation was found to be dependent on actin-
stress ﬁbers. Interestingly, recent experiments suggest that
diﬀerent S100 proteins utilize distinct translocation pathways,
which might guide them to certain subcellular compartments
in order to perform their physiological tasks in the same cel-
lular environment [17].
The most diverse behavior with respect to the association to
the lipid rafts is shown for the S100A8 and S100A9 proteins.
Both are known to form heterodimers. In summary, the
S100A9/A8 membrane association is calcium-dependent, de-
tergent resistant and lipid raft independent. The calcium-
dependent association with membranes and the cytoskeleton is
detergent resistant as shown in this study. However, it is re-
markable that both proteins are not exclusively located in the
typical lipid raft containing fractions. Instead, both proteins
are also found in the chlolesterol-free, but lipid-rich fractions
as conﬁrmed by the cholesterol depletion experiment, sug-
gesting that they bind in a detergent resistant manner to other
lipid structures than to the cholesterol and sphingolipid rich
lipid rafts. In this context, it is worth mentioning that the early
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the rafts in cells appear to be heterogeneous both in terms of
their protein and their lipid content [18] and our data indicate
that S100A8/A9 may associate to lipid structures other than
the typical cholesterol and sphingolipid rich rafts. Further-
more, tubulin dissociating agents seem to inhibit this translo-
cation. This agrees well with the ﬁnding that secretion of
S100A8/A9 occurs via a tubulin-dependent mechanism [19].
PMA elicits a strong oxidative burst reaction. The S100A8/
A9 complex has been described as a stimulatory cofactor for
the phagocytic NADPH oxidase [20]. The membrane bound
NADPH oxidase subunits are present in lipid rafts [21].
Stimulation of the cells with the phorbol ester PMA alone does
not result in detergent resistant membrane (DRM) association
of S100A8/A9. This strengthens the observation that calcium is
essential for the DRM S100A9/A8 association and further
suggests that the S100A8/A9 mediated stimulation of the
NADPH oxidase activity is most likely mediated by detergent
sensitive protein–protein interaction with the subunits of the
NADPH oxidase and is not dependent on a calcium-dependent
membrane localization of the S100 proteins.
Taken together, our ﬁndings provide new biochemical evi-
dence that the family of EF-hand and S100 proteins play di-
verse roles in the membrane of granulocytes.
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